반응 #2186204

ord-962f677f8f5d4da8804e192289d9fb6e

반응 방정식

O=c1oc2cc(N3CCNCC3)ccc2cc1-c1nc2ccccc2s1
3-Benzothiazol-2-yl-7-piperazin-1-yl-chromen-2-one
O=C([O-])[O-].[Cs+].[Cs+]
cesium carbonate
CN1CCN(c2ccc3cc(-c4nc5ccccc5s4)c(=O)oc3c2)CC1
desired product
수율 47.3%
CN1CCN(c2ccc3cc(-c4nc5ccccc5s4)c(=O)oc3c2)CC1
3-Benzothiazol-2-yl-7-(4-methyl-piperazin-1-yl)-chromen-2-one
수율 47.3%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    온도cooled below 5° C.
  2. 2
    workup.ADDITIONtreated with 1 eq (0.018 mL) Mel
  3. 3
    세척washed twice with ice-water
  4. 4
    기타The organic phase is evaporated
  5. 5
    기타the residue column chromatographed (silica gel, dichloromethane/EtOH 9:1)
  6. 6
    기타Recrystallization from methanol/dichloromethane

실험 절차

100 mg (0.28 mmol) 3-Benzothiazol-2-yl-7-piperazin-1-yl-chromen-2-one were dissolved in 15 mL DMF and treated under argon with 183 mg (2 eq.) cesium carbonate, cooled below 5° C. and treated with 1 eq (0.018 mL) Mel. After stirring for 4 h, the reaction mixture is diluted with 100 mL dichloromethane and washed twice with ice-water. The organic phase is evaporated and the residue column chromatographed (silica gel, dichloromethane/EtOH 9:1). Recrystallization from methanol/dichloromethane yields 50 mg (47%) desired product as an orange powder.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07569337B2uspto-grants-2009_08